A Retrospective Observational Study of Patients With Early-stage HER2-positive Breast Cancer, Treated With Neratinib

NCT05599334 · clinicaltrials.gov ↗

COMPLETED

Status

111

Enrollment

INDUSTRY

Sponsor class

Conditions

Breast Cancer
Adjuvant Therapy
HER2-positive Breast Cancer

Sponsor

Pierre Fabre Medicament

Collaborators

[object Object]